KFDA approves new statin preparation for lowering cholesterol

Published: 2003-11-06 06:59:00
Updated: 2003-11-06 06:59:00
The Korea Food and Drug Administration said it approved AstraZeneca's Crestor (rosuvastatin) for treatment of hypercholestrolemia and mixed hyperlipidemia.

Crestor is in the class of drug called HMG-CoA reductase inhibitors, also known as statins. The lipid-lowering agent work by partially blo...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.